Zoetis Inc. — Financial Statements & Ratios

ZTS

NYSEHealthcareDrug Manufacturers - Specialty & GenericCIK 0001555280zoetis.comAbout ZTS

Last close · Oct 16, 202679.32+0.90 (+1.15%)

Market cap$32.8B

Key indicators

Revenue9.5BTTM+1.4% on a year earlier+7.2% a year, FY2018–FY2025

5.8B

6.3B

6.7B

7.8B

8.1B

8.5B

9.3B

9.5B

9.3B

9.4B

9.8B

Fiscal year

FY201818

FY201919

FY202020

FY202121

FY202222

FY202323

FY202424

FY202525

TTMTTM

FY2026E26E

FY2027E27E

FY2028E28E

Fiscal year	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	TTM	FY2026E	FY2027E	FY2028E
Growth
	5.8B	6.3B+7.5%	6.7B+6.6%	7.8B+16.5%	8.1B+3.9%	8.5B+5.7%	9.3B+8.3%	9.5B+2.3%	9.5B+1.4%	9.3B	9.4B	9.8B
	—	7.5%	6.6%	16.5%	3.9%	5.7%	8.3%	2.3%	1.4%	-2.2%	1.5%	4.1%
	$2.93	$3.11+6.1%	$3.42+10.0%	$4.27+24.9%	$4.49+5.2%	$5.07+12.9%	$5.47+7.9%	$6.02+10.1%	$6.07+4.5%	$6.21	$6.41	$6.92
Profitability
	24.5%	24.0%−0.6 pt	24.5%+0.6 pt	26.2%+1.7 pt	26.2%−0.0 pt	27.4%+1.3 pt	26.9%−0.6 pt	28.2%+1.4 pt	27.5%−0.3 pt	·	·	·
	65.4%	55.4%−10.0 pt	43.5%−11.9 pt	44.8%+1.4 pt	48.0%+3.2 pt	46.9%−1.1 pt	52.1%+5.2 pt	80.2%+28.1 pt	—	·	·	·
Cash
	1.5B	1.3B−8.1%	1.7B+25.3%	1.7B+3.8%	1.3B−23.6%	1.6B+22.2%	2.3B+41.8%	2.3B−0.7%	2.4B+6.6%	·	·	·
	24.9%	21.3%−3.6 pt	25.1%+3.7 pt	22.3%−2.7 pt	16.4%−5.9 pt	19.0%+2.6 pt	24.8%+5.9 pt	24.1%−0.7 pt	24.9%+1.2 pt	·	·	·
Balance sheet
	2.95x	2.38x−0.57x	1.91x−0.47x	1.45x−0.46x	1.79x+0.34x	1.31x−0.48x	1.38x+0.06x	2.71x+1.34x	2.87x+1.55x	·	·	·
	486.90M	481.79M−1.0%	478.57M−0.7%	476.72M−0.4%	470.38M−1.3%	462.27M−1.7%	454.85M−1.6%	443.83M−2.4%	417.70M−6.2%	·	·	·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.